Edition:
United Kingdom

Zafgen Inc (ZFGN.OQ)

ZFGN.OQ on NASDAQ Stock Exchange Global Select Market

8.37USD
16 Feb 2018
Change (% chg)

$0.24 (+2.95%)
Prev Close
$8.13
Open
$8.16
Day's High
$8.47
Day's Low
$8.16
Volume
52,990
Avg. Vol
39,264
52-wk High
$9.26
52-wk Low
$3.21

Select another date:

Fri, Jan 5 2018

BRIEF-Zafgen Says Co Entered Into Loan And Security Agreement Providing For Term Loan With Principal Amount​ Of $20 Mln

* ZAFGEN SAYS ‍ON DEC 29, CO ENTERED INTO LOAN AND SECURITY AGREEMENT PROVIDING FOR TERM LOAN WITH PRINCIPAL AMOUNT​ OF $20 MILLION - SEC FILING Source text: [http://bit.ly/2Earwn6] Further company coverage:

BRIEF-Zafgen Reports Strong Clinical Progress And Updates Outlook For 2018

* ZAFGEN REPORTS STRONG CLINICAL PROGRESS AND UPDATES OUTLOOK FOR 2018

BRIEF-Zafgen reports Q3 loss per share $0.46

* Q3 earnings per share view $-0.58 -- Thomson Reuters I/B/E/S

BRIEF-Zafgen appoints Jeffrey Hatfield as CEO

* Zafgen appoints Jeffrey Hatfield as Chief Executive Officer; Thomas Hughes, Ph.D. to continue as president, appointed chief scientific officer

BRIEF-Zafgen initiates Phase 2 clinical trial for ZGN-1061

* Zafgen initiates Phase 2 clinical trial for ZGN-1061 in patients with Type 2 diabetes Source text for Eikon: Further company coverage:

Select another date: